Ignite Creation Date:
2025-12-24 @ 2:39 PM
Ignite Modification Date:
2025-12-30 @ 1:11 AM
Study NCT ID:
NCT02159859
Status:
COMPLETED
Last Update Posted:
2018-10-17
First Post:
2014-06-03
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Pharmacokinetics and Optimal Dose of Ertapenem in Hemodialysis Patients
Sponsor:
Corewell Health East
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
OH-D-Ertapenem-HD
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | OTHER | View |